Focused on the Development & Commercialization of Innovative Plasma-Based Bioactive Materials

Carmell Therapeutics Corporation is a privately-owned biosurgical technology company focused on the development and commercialization of innovative plasma-based bioactive materials. Carmell’s proprietary blood plasma-based technology is the foundation for groundbreaking products designed to improve the lives of patients and reduce the costs of healthcare across a variety of surgical procedures.